Ownership history in MACQUARIE GROUP LTD · 12 quarters on record
This page tracks every 13F SEC filing in which MACQUARIE GROUP LTD reported a position in VAXCYTE INC (PCVX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 80,000 | — | 0% | 0.00% | $2.9M | $36.02 |
| 2025 Q2 | REDUCED | 80,000 | -109,793 | -57.8% | 0.00% | $2.6M | $32.51 |
| 2025 Q1 | REDUCED | 189,793 | -58,241 | -23.5% | 0.01% | $7.2M | $37.76 |
| 2024 Q4 | ADDED | 248,034 | +39,159 | +18.7% | 0.02% | $20.3M | $81.86 |
| 2024 Q3 | ADDED | 208,875 | +49,863 | +31.4% | 0.03% | $23.9M | $114.27 |
| 2024 Q2 | ADDED | 159,012 | +159,012 | — | 0.01% | $12.0M | $75.51 |
| 2022 Q3 | REDUCED | — | -928 | -100.0% | 0.00% | $22K | $24.00 |
| 2022 Q2 | UNCHANGED | 928 | — | 0% | 0.00% | $20K | $21.76 |
| 2022 Q1 | UNCHANGED | 928 | — | 0% | 0.00% | $22K | $24.15 |
| 2021 Q4 | REDUCED | 928 | -1,064 | -53.4% | 0.00% | $22K | $23.79 |
As of 2025 Q4 — sorted by position size